Various pathways contribute to a cumulative pro-inflammatory state in MetS, with elevated Interleukin-6 (IL-6), C-reactive protein, and tumor necrosis factor alpha (TNFα) among these individuals. Here, IL6 is linked to metabolic syndrome.